Tag: Horizontal

FTC Seeks Public Comment on Petition to Modify Exxon-Pioneer Final Order

Date

April 11, 2025

The Federal Trade Commission seeks public comment on a petition filed by Scott Sheffield, the founder and former CEO of Pioneer Natural Resources, requesting that the Commission reopen and set aside a...

FTC Seeks Public Comment on Petition to Modify Chevron-Hess Final Order

Date

April 11, 2025

The Federal Trade Commission is seeking public comment on a petition filed by Chevron Corporation and Hess Corporation requesting that the Commission reopen and set aside a final consent order...

Rules

HSR Rules

Rule Updated Date

April 10, 2025

The HSR Rules outline the requirements for the premerger notification process under the Hart-Scott-Rodino (HSR) Act, which enables the Federal Trade Commission and the Antitrust Division of the...

Text of Rule

FTC Requests Public Comment on EnCap, Verdun, XCL Petition to Modify Order

Date

April 2, 2025

The Federal Trade Commission is seeking public comment on a petition to reopen and modify a 2022 final consent order involving Verdun Oil Company II LLC’s (Verdun) acquisition of EP Energy LLC (EP)...

Federal Register Notice

Petition of EnCap Investments L.P., et al., To Reopen and Modify Order

Date

March 31, 2025

Federal Register Notice

Welsh, Carson, Anderson & Stowe; Analysis of Agreement Containing Consent Order To Aid Public Comment

Date

February 18, 2025

Federal Register Notice

Petition of Enbridge Inc. To Reopen and Set Aside Order

Date

January 30, 2025

Adjudicative Proceedings

Tapestry, Inc./Capri Holdings Limited, In the Matter of

Type of Action

Administrative

Last Updated

December 5, 2024

FTC Matter/File Number

231 0133

Docket Number

9429

Case Status

Closed

Federal Register Notice

Chevron Corporation and Hess Corporation; Analysis of Agreement Containing Consent Order To Aid Public Comment

Date

October 3, 2024

Report on Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies (2.47 MB)

Statement of Commissioner Rebecca Kelly Slaughter Regarding FTC Staff Interim Report: Pharmacy Benefit Managers

Date

August 1, 2024

Rebecca Kelly Slaughter, Former Commissioner

Statement of Commissioner Rebecca Kelly Slaughter Regarding FTC Staff Interim Report: Pharmacy Benefit Managers (187.83 KB)

Report

Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies

Date

July 9, 2024

Dissenting Statement of Commissioner Melissa Holyoak In the Matter of the Pharmacy Benefit Managers Report

Date

July 9, 2024

Melissa Holyoak, Former Commissioner

Dissenting Statement of Commissioner Melissa Holyoak In the Matter of the Pharmacy Benefit Managers Report (226.67 KB)

Concurring Statement of Commissioner Andrew N. Ferguson Regarding the Pharmacy Benefit Managers Interim Staff Report

Date

July 9, 2024

Andrew N. Ferguson, Chairman

Concurring Statement of Commissioner Andrew N. Ferguson Regarding the Pharmacy Benefit Managers Interim Staff Report (231.68 KB)

Statement of Chair Lina M. Khan Joined by Commissioners Alvaro M. Bedoya & Rebecca Kelly Slaughter Regarding the Pharmacy Benefit Managers Interim Staff Report (202.52 KB)

Statement of Chair Lina M. Khan Joined by Commissioners Alvaro M. Bedoya & Rebecca Kelly Slaughter Regarding the Pharmacy Benefit Managers Interim Staff Report

Date

July 9, 2024

Lina M. Khan, Former Chair and Commissioner;

Alvaro Bedoya, Former Commissioner;

Rebecca Kelly Slaughter, Former Commissioner

FTC Releases Interim Staff Report on Prescription Drug Middlemen

Date

July 9, 2024

The Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and...

Statement Regarding the Termination of Novant Health’s Acquisition of Hospitals from Community Health Systems

Date

July 1, 2024

Federal Trade Commission Bureau of Competition Director Henry Liu issued the following statement in response to Novant Health, Inc.’s decision to terminate its proposed acquisition of two hospitals...